Gene expression profiling in early breast cancer treated with neoadjuvant ribociclib plus letrozole (R+L) versus chemotherapy (CT): A correlative analysis of the SOLTI-1402/CORALLEEN phase II trial
F. Schettini1, N. Chic2, F. Brasó-Maristany1, L. Paré3, T. Pascual4, B. Conte5, O. Martinez Saez6, B. Adamo6, M. Vidal2, A. Fernandez-Martinez7, B. González-Farré8, E. Sanfeliu8, G. Perrone9, P. Villagrasa3, J. Gavila Gregori10, C.H. Barrios11, A. Lluch12, M. Martin Jimenez13, S. De Placido14, A. Prat15
Communication in congress
ePoster
ESMO BREAST
2020
